Navigation Links
CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase
Date:10/9/2008

54) (1,162) (1,582) (4,011)

Other expense, net (175) (232) (533) (680)

Loss before income taxes and minority

interest (429) (1,394) (2,115) (4,691)

Minority interest in income of

subsidiary - (11) (145) (45)

Income tax benefit (provision) (3) 56 (519) (195)

Loss from continuing operations (432) (1,349) (2,779) (4,931)

Income (loss) from discontinued

operations - 496 127 (10,614)

Net loss $(432) $(853) $(2,652) $(15,545)

Net loss per common share:

Basic and diluted $(0.06) $(0.12) $(0.37) $(2.22)

Weighted-average shares used in per

share calculation:

Basic and diluted 7,213 7,031 7,171 7,004

Selected Consolidated Balance Sheet Data

August 31, November 30,

2008 2007

Cash and cash equivalents $6,328 $8,362

Accounts receivable, net 3,861 4,475

Inventory, net 1,195 1,670

Total current assets 11,942 15,164

Long-term assets 4,451 4,703

Total assets 16,393 19,867

Total current liabilities 7,885 5,620

Long-term liabilities 879 4,318

Total liabilities 8,764 9,938

Minority interest 478 407

Shareholders'
'/>"/>

SOURCE CardioDynamics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. CardioDynamics BioZ(R) ICG Technology Integrates with General Electric Healthcares Centricity(R) Electronic Medical Record (EMR) System
2. CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Companys Common Stock and Trading in Post-split Shares Begins May 9, 2008
3. CardioDynamics Receives Nasdaq Letter of Non-Compliance With Minimum Bid Price Requirement
4. CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series
5. CardioDynamics Ranked in Deloittes Technology Fast 50 Program for San Diego
6. CardioDynamics Receives FDA 510(k) Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility
7. CardioDynamics Provides 2007 Shareholder Meeting Update
8. Paper in Cell Cycle Reports Alfacells ONCONASE(R) Targets siRNA
9. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
10. TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting With FDA for Tezampanel
11. Corgenix Reports Fiscal 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)...  MiMedx Group, Inc. (NASDAQ: MDXG ), the ... patent-protected processes to develop and market advanced products and ... Medicine, Ophthalmic and Dental sectors of healthcare, announced that ... been awarded the Lifetime Achievement Award in the EY ... The Entrepreneur Of The Year Program, now in ...
(Date:6/29/2015)... June 29, 2015   Veracyte, Inc . (Nasdaq: ... field of molecular cytology, today announced that it has ... Top Workplaces list for the second year in a ... solely on an annual survey of Bay Area-company employees. ... the degree to which Veracyte values our employees and ...
(Date:6/26/2015)... , June 26, 2015   Aratana ... a pet therapeutics company focused on the ... products for companion animals, today announced positive ... of capromorelin (AT-002), the company,s innovative therapeutic ... a small molecule that mimics ghrelin, the ...
(Date:6/26/2015)... NEW YORK and MUMBAI, India ... (TCS), (BSE: 532540, NSE: TCS) a leading global IT ... has been designated as a Leader in Worldwide Life ... IDC, in the " IDC MarketScape: Worldwide Life Science ... 2015) report. The report evaluated eight ...
Breaking Biology Technology:EY Entrepreneur Of The Year Program Recognizes Pete Petit, The Chairman & CEO of MiMedx 2Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 2Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 2Aratana Therapeutics Announces Positive Pivotal Results for AT-002 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 4Aratana Therapeutics Announces Positive Pivotal Results for AT-002 5TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 2TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 3TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 4
... , , , ... 20 The Molecular Genetics Core Facility (MGCF) at ... genetics researchers to conduct the highly economic targeted enrichment of ... will be receiving the Geniom RT Analyzer® from febit to ...
... , Washington , Jan. ... Alnylam announced today that the organizations are partnering to engage the ... and Alnylam Intellectual Property (IP) Pool.  The IP Pool was formed ... development of new medicines for the treatment of 16 neglected tropical ...
... ... (IPS), a leading, full-service engineering, construction, commissioning and qualification company dedicated to assisting ... Wareheim as Bioprocess Subject Matter Expert. , ... Lafayette Hill, PA (Vocus) January 20, 2010 ...
Cached Biology Technology:Molecular Genetics Core Facility at Children's Hospital Boston Selects HybSelect from febit for Targeted Resequencing 2Molecular Genetics Core Facility at Children's Hospital Boston Selects HybSelect from febit for Targeted Resequencing 3BIO Ventures for Global Health Chosen to Administer the GSK and Alnylam Intellectual Property Pool 2BIO Ventures for Global Health Chosen to Administer the GSK and Alnylam Intellectual Property Pool 3BIO Ventures for Global Health Chosen to Administer the GSK and Alnylam Intellectual Property Pool 4IPS Appoints Dave Wareheim as Bioprocess Subject Matter Expert 2IPS Appoints Dave Wareheim as Bioprocess Subject Matter Expert 3
(Date:6/23/2015)... Minn. , June 23, 2015   ... company that supports the entire spectrum of clinical ... iMedNet ™ , the company,s intuitive, ... been awarded a Silver 2015 Stevie® Award by ... Health Products & Services Website category.  The American ...
(Date:6/18/2015)... , June 18, 2015 This report analyzes ... by the following Product Segments, which includes Immunoassay Analyzers ... Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems. ... Canada , Japan ... , Latin America , and ...
(Date:6/17/2015)... June 17, 2015  Synaptics Inc. (NASDAQ: ... today announced that Xiaomi, one of the world,s ... ClearPad ® family of capacitive touchscreen ... circuits (DDICs) for its latest smartphones, the Xiaomi ... for full in-cell display solutions and DDICs in ...
Breaking Biology News(10 mins):MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2Global Immunoassay Systems Market 2Global Immunoassay Systems Market 3Global Immunoassay Systems Market 4Global Immunoassay Systems Market 5Global Immunoassay Systems Market 6Global Immunoassay Systems Market 7Global Immunoassay Systems Market 8Global Immunoassay Systems Market 9Global Immunoassay Systems Market 10Global Immunoassay Systems Market 11Global Immunoassay Systems Market 12Global Immunoassay Systems Market 13Global Immunoassay Systems Market 14Global Immunoassay Systems Market 15Global Immunoassay Systems Market 16Global Immunoassay Systems Market 17Global Immunoassay Systems Market 18Global Immunoassay Systems Market 19Global Immunoassay Systems Market 20Global Immunoassay Systems Market 21Global Immunoassay Systems Market 22Global Immunoassay Systems Market 23Global Immunoassay Systems Market 24Global Immunoassay Systems Market 25Global Immunoassay Systems Market 26Global Immunoassay Systems Market 27Global Immunoassay Systems Market 28Global Immunoassay Systems Market 29Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3
... be the key to creating cyborg interfaces? Circuitry that links ... such as a robotic limb or artificial eye might one ... Writing in the International Journal of Medical Engineering ... "memristor" can be made using human blood. Memristors were a ...
... (Baltimore, MD) Today, the Interactive Autism Network (IAN), ... first major survey to study the experience of wandering ... disorders (ASD). The tendency of individuals with ASD to ... injury or even death, yet information on this critical ...
... State University has revealed a potential new way for plants ... and molecular biology professor, cites that this defense mechanism is ... plants and herbivores. Howe, in the current issue of ... offers insights to understanding the chemical weaponry of this war, ...
Cached Biology News:Blood simple circuitry for cyborgs 2Why do children with autism wander and bolt from safe places? 2The way to (kill) a bug's heart is through its stomach 2
Mouse monoclonal antibody raised against a partial recombinant ALPK3. NCBI Entrez Gene ID = ALPK3...
Mouse monoclonal antibody raised against a partial recombinant MYO7A. NCBI Entrez Gene ID = MYO7A...
... Cell Lines ,High Quality, Functionally-Validated, Ion Channel ... known for having a critical role in ... a key function in pain, CNS and ... have been investigated in therapeutic areas, such ...
Mouse monoclonal antibody raised against a partial recombinant ENTPD5. NCBI Entrez Gene ID = ENTPD5...
Biology Products: